background human metapneumoviru hmv infect caps act lower respiratory tract ill infant immunocompromis elderly current license prevent measure infect use variant hmpvnl require trypsin supplement growth tissue culture delete gene value replica rampÎ´m virus vitro vivo result studi show about increase process insert u nucleotide poly tract genome rna admit viral transcript upregul although level remain compare ramp thu delete alter ratio genome copy transcript attend compare lung nasal turbine hamster immune one dose protect challenge pf wild type wt concur suggest regal influence fide polymerase complex hamster model protect suggest may result potent live vaccine candid thorough knowledge role studi develop lack express 